Enasidenib for patients with relapsed acute myeloid leukemia and the IDH2 mutation

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	247-249
Number of pages	3
Journal	Clinical Advances in Hematology and Oncology
Volume	16
Issue number	4
State	Published - Apr 2018

ASJC Scopus subject areas

@article{4f9776e540ca4ad2831ec0c85ddc5c47,

title = "Enasidenib for patients with relapsed acute myeloid leukemia and the IDH2 mutation",

author = "Courtney Dinardo",

year = "2018",

month = apr,

language = "English (US)",

volume = "16",

pages = "247--249",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "4",

}

TY - JOUR

T1 - Enasidenib for patients with relapsed acute myeloid leukemia and the IDH2 mutation

AU - Dinardo, Courtney

PY - 2018/4

Y1 - 2018/4

UR - http://www.scopus.com/inward/record.url?scp=85048221416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048221416&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 29742078

AN - SCOPUS:85048221416

SN - 1543-0790

VL - 16

SP - 247

EP - 249

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 4

ER -